Holen Sie sich die Stockscreener-App
8.68
1.28%
-0.11
Schlusskurs vom Vortag:
$8.79
Offen:
$8.73
24-Stunden-Volumen:
25,336
Relative Volume:
0.02
Marktkapitalisierung:
$679.39M
Einnahmen:
$400.05M
Nettoeinkommen (Verlust:
$181.01M
KGV:
4.1347
EPS:
2.0993
Netto-Cashflow:
$194.71M
1W Leistung:
+10.55%
1M Leistung:
+3.80%
6M Leistung:
-22.31%
1J Leistung:
-24.01%
1-Tages-Spanne:
$8.6401
$8.74
1-Wochen-Bereich:
$7.98
$8.89
52-Wochen-Spanne:
$6.125
$14.96
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
8.66 | 615.85M | 400.05M | 181.01M | 194.71M | 2.0993 |
VRTX
Vertex Pharmaceuticals Inc
|
515.50 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
665.06 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
929.14 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.97 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.14 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
Liquidity Mapping Around (CRMD) Price Events - Stock Traders Daily
CRMD,PEP Revenue Breakdown - Finviz
CORMEDIX INC. Files 8-K: Company Details, Stock Info & SEC Filing Summary for June 25, 2026 - Minichart
CorMedix (NASDAQ: CRMD) replaces CBIZ with Ernst & Young as auditor - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Yahoo Finance
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - TradingView
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path - TradingView
CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
CorMedix Inc. (CRMD) Slips 2.74% as Stock Tests Support Near $7.25Volatility Smirk - dars.gov.et
CorMedix Inc.(NasdaqGM: CRMD) added to Russell 2000 Value Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) added to Russell Microcap Value Benchmark Index - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
Enterprise value to EBIT forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
Price to book forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Price to sales forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Is Now The Time To Put CorMedix (NASDAQ:CRMD) On Your Watchlist? - Moomoo
Price to earnings forward of CorMedix Inc. – NASDAQ:CRMD - TradingView
Form DEF 14A CorMedix Inc For: 25 June - Investing.com UK
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
Form DEF 14A CorMedix Inc For: 25 June By Investing.com - Investing.com Australia
CorMedix Inc. Actuals & Estimates (NASDAQ:CRMD) - TradingView
CRMD Forecast — Price Target — Prediction for 2027 - TradingView
CorMedix (CRMD) shareholders affirm directors but vote down multiple charter amendments - Stock Titan
CorMedix Inc (CRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why (CRMD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Raised 2026 Guidance and DefenCath Momentum Might Change The Case For Investing In CorMedix (CRMD) - simplywall.st
CorMedix Inc (CRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CorMedix Inc. (CRMD) Achieves Remarkable 384.60% Revenue Growth - GuruFocus
CorMedix Inc (CRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CorMedix Inc (CRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CorMedix Inc (CRMD) Institutional Confidence - TradingKey
CorMedix Inc (CRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CorMedix Inc (CRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CorMedix Inc (CRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CorMedix Inc (CRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
CorMedix (CRMD) Stock Could Be 27.8% Undervalued After Q1 Results And Raised Outlook - Yahoo Finance
The Bull Case For CorMedix (CRMD) Could Change Following Raised 2026 Guidance And DefenCath MomentumLearn Why - Yahoo Finance
CorMedix Inc. (CRMD) Reports Q1 2026 Results - Insider Monkey
CorMedix (CRMD) holder reports 4.62M shares, 5.89% stake - Stock Titan
CorMedix (CRMD): Investor reports 4.62M shares, 5.89% stake - Stock Titan
5 Most Profitable Small Cap Stocks to Buy - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
CRMD Q1 2026 Earnings: EPS Beat of 31.72% Drives Stock HigherProfit Recovery Report - newsline.com
Federal appeals court upholds CorMedix patent win over Nexus - Investing.com UK
Federal Circuit Affirms CorMedix Patent Victory, Blocking Nexus Generic MINOCIN® Launch Until Patent Expiration 1 - minichart.com.sg
Federal appeals court upholds CorMedix patent win over Nexus By Investing.com - Investing.com South Africa
Appeals court upholds CorMedix (NASDAQ: CRMD) MINOCIN® patents and injunction - Stock Titan
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.95%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):